Elizabeth Bukusi, MBChB, MMed, MPH, PhD

Research Professor, Global Health

Research Professor, Obstetrics and Gynecology

 

Elizabeth Bukusi, MBChB, MMed, MPH, PhD, is a chief research officer at the Kenya Medical Research Institute (KEMRI), a research professor at the University of Washington ( Departments of Obstetrics and Gynecology and Global Health), and volunteer faculty member at the University of California San Francisco, Department of Obstetrics and Gynecology and Reproductive sciences. She is a visiting scientist at the University of Nairobi, an honorary lecturer at Aga Khan University in Nairobi, and is faculty at the Centre for Biomedical Ethics and Culture at the Sind Institute for urology and transplantation Karachi. Her primary research interest includes STIs, reproductive health, and HIV prevention, care, and treatment in addition to an interest in ethics and the development of systems and structures for regulating research, She has had a focus on capacity building for many years and has been engaged in the training and mentorship young scientists. She serves on many international boards, task forces, and committees and is a co-lead on the IARTP Women and HIV program.

Publications

  1. Gitome, S, Musara, P, Chitukuta, M, Mhlanga, F, Mateveke, B, Chirenda, T et al.. "First was to sit down and bring our minds together". A qualitative study on safer conception decision-making among HIV sero-different couples in Zimbabwe. Sex Reprod Health Matters. 2024;32 (1):2366587. doi: 10.1080/26410397.2024.2366587. PubMed PMID:39007699 .
  2. Miller, L, Otieno, B, Amboka, S, Kadede, K, Odeny, D, Odhiambo, H et al.. "Something Like That": Awareness and Acceptability of HIV PrEP and PEP Among Kenyan Adolescents. Int J Behav Med. 2024; :. doi: 10.1007/s12529-024-10290-6. PubMed PMID:38942977 .
  3. Ngongo, CJ, Raassen, TJIP, van Roosmalen, J, Mahendeka, M, Lombard, L, Bukusi, E et al.. Equivalence between physicians and associate clinicians in the frequency of iatrogenic urogenital fistula following cesarean section in Tanzania and Malawi. Hum Resour Health. 2024;22 (1):43. doi: 10.1186/s12960-024-00927-8. PubMed PMID:38915096 PubMed Central PMC11197166.
  4. Lagat, HK, Pintye, J, Harrington, E, Houck, S, Kwena, Z, Lenn, M et al.. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial. Trials. 2024;25 (1):394. doi: 10.1186/s13063-024-08206-6. PubMed PMID:38890744 PubMed Central PMC11186170.
  5. Mungo, C, Omoto, J, Ogollah, C, Owaya, A, Rop, M, Rota, G et al.. Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial. medRxiv. 2024; :. doi: 10.1101/2024.06.06.24308548. PubMed PMID:38883743 PubMed Central PMC11178019.
Search PubMed

Comments are closed.